BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 29288743)

  • 1. The good and bad faces of the CXCR4 chemokine receptor.
    Teixidó J; Martínez-Moreno M; Díaz-Martínez M; Sevilla-Movilla S
    Int J Biochem Cell Biol; 2018 Feb; 95():121-131. PubMed ID: 29288743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting CXCL12/CXCR4 Axis in Tumor Immunotherapy.
    Zhou W; Guo S; Liu M; Burow ME; Wang G
    Curr Med Chem; 2019; 26(17):3026-3041. PubMed ID: 28875842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion.
    Kucia M; Jankowski K; Reca R; Wysoczynski M; Bandura L; Allendorf DJ; Zhang J; Ratajczak J; Ratajczak MZ
    J Mol Histol; 2004 Mar; 35(3):233-45. PubMed ID: 15339043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CXCL12 (SDF-1)/CXCR4 chemokine axis: Oncogenic properties, molecular targeting, and synthetic and natural product CXCR4 inhibitors for cancer therapy.
    Zhou Y; Cao HB; Li WJ; Zhao L
    Chin J Nat Med; 2018 Nov; 16(11):801-810. PubMed ID: 30502762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic roles and drug target of CXCR4/CXCL12 axis in lung cancer and cancer stem cell.
    Wang Z; Sun J; Feng Y; Tian X; Wang B; Zhou Y
    Tumour Biol; 2016 Jul; 37(7):8515-28. PubMed ID: 27079871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for chemokine recognition by a G protein-coupled receptor and implications for receptor activation.
    Ziarek JJ; Kleist AB; London N; Raveh B; Montpas N; Bonneterre J; St-Onge G; DiCosmo-Ponticello CJ; Koplinski CA; Roy I; Stephens B; Thelen S; Veldkamp CT; Coffman FD; Cohen MC; Dwinell MB; Thelen M; Peterson FC; Heveker N; Volkman BF
    Sci Signal; 2017 Mar; 10(471):. PubMed ID: 28325822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCL12/CXCR4 signal transduction in diseases and its molecular approaches in targeted-therapy.
    Mousavi A
    Immunol Lett; 2020 Jan; 217():91-115. PubMed ID: 31747563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCL12 (SDF-1)/CXCR4 pathway in cancer.
    Teicher BA; Fricker SP
    Clin Cancer Res; 2010 Jun; 16(11):2927-31. PubMed ID: 20484021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis.
    Kucia M; Reca R; Miekus K; Wanzeck J; Wojakowski W; Janowska-Wieczorek A; Ratajczak J; Ratajczak MZ
    Stem Cells; 2005 Aug; 23(7):879-94. PubMed ID: 15888687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression.
    Sun X; Cheng G; Hao M; Zheng J; Zhou X; Zhang J; Taichman RS; Pienta KJ; Wang J
    Cancer Metastasis Rev; 2010 Dec; 29(4):709-22. PubMed ID: 20839032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokine receptor CXCR4: role in gastrointestinal cancer.
    Lombardi L; Tavano F; Morelli F; Latiano TP; Di Sebastiano P; Maiello E
    Crit Rev Oncol Hematol; 2013 Dec; 88(3):696-705. PubMed ID: 24120239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CXCL12/CXCR4 axis as a therapeutic target in cancer and HIV-1 infection.
    Patrussi L; Baldari CT
    Curr Med Chem; 2011; 18(4):497-512. PubMed ID: 21143114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCR4 in breast cancer: oncogenic role and therapeutic targeting.
    Xu C; Zhao H; Chen H; Yao Q
    Drug Des Devel Ther; 2015; 9():4953-64. PubMed ID: 26356032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signal transmission through the CXC chemokine receptor 4 (CXCR4) transmembrane helices.
    Wescott MP; Kufareva I; Paes C; Goodman JR; Thaker Y; Puffer BA; Berdougo E; Rucker JB; Handel TM; Doranz BJ
    Proc Natl Acad Sci U S A; 2016 Aug; 113(35):9928-33. PubMed ID: 27543332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescent CXCL12AF647 as a novel probe for nonradioactive CXCL12/CXCR4 cellular interaction studies.
    Hatse S; Princen K; Liekens S; Vermeire K; De Clercq E; Schols D
    Cytometry A; 2004 Oct; 61(2):178-88. PubMed ID: 15382150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXC chemokine ligand 12 (CXCL12) and its receptor CXCR4.
    Nagasawa T
    J Mol Med (Berl); 2014 May; 92(5):433-9. PubMed ID: 24722947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis of the interactions between CXCR4 and CXCL12/SDF-1 revealed by theoretical approaches.
    Xu L; Li Y; Sun H; Li D; Hou T
    Mol Biosyst; 2013 Aug; 9(8):2107-17. PubMed ID: 23702796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Pathways: Targeting the CXCR4-CXCL12 Axis--Untapped Potential in the Tumor Microenvironment.
    Scala S
    Clin Cancer Res; 2015 Oct; 21(19):4278-85. PubMed ID: 26199389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of CXCL12 and Its Receptors on Unpredictable Renal Cell Carcinoma.
    Floranović MP; Veličković LJ
    Clin Genitourin Cancer; 2020 Aug; 18(4):e337-e342. PubMed ID: 31882334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dysfunctions of the CXCL12 (SDF-1)/CXCR4 signaling axis in the WHIM syndrome and the idiopathic CD4(+) T-cell lymphocytopenia].
    Biajoux V; Bignon A; Bouchet-Delbos L; Emilie D; Balabanian K
    Biol Aujourdhui; 2010; 204(4):273-84. PubMed ID: 21215244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.